Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN1197447A discloses a robust method for resolving racemates like selegiline and ephedrine using stable phenoxypropionic acid derivatives, offering high purity and scalable manufacturing advantages.
Patent CN118480071A reveals a novel manganese complex for asymmetric hydrogenation, offering cost reduction and high purity for pharmaceutical intermediates manufacturing.
Novel scalable route for L-penicillamine HCl via efficient racemization and resolution. Delivers high-purity pharmaceutical intermediates with optimized cost structures.
Novel resolution method for high-purity pharmaceutical intermediates. Cost-effective scale-up and supply chain reliability for kinase inhibitor synthesis.
Novel method for genotoxic impurity standard. High purity over 98 percent. Cost effective supply chain solutions for pharmaceutical intermediates.
Patent CN114539353B reveals solid phase synthesis for pemetrexed metabolites. Enhances purity and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN108191898B reveals a novel synthesis for low-toxicity benzoborazole chalcones. Discover cost-effective manufacturing and scalable supply chain solutions for pharmaceutical intermediates.
Patent CN108779133A reveals a novel crystallization-induced dynamic resolution for Tenofovir Alafenamide, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN102020679A reveals a superior oxalate-based synthesis for Lobaplatin Trihydrate, offering enhanced stability, higher yields, and streamlined purification for API manufacturing.
Patent CN101293889B details a novel glycosylation method for artemisinin. Enhance solubility and reduce toxicity with our scalable pharmaceutical intermediate manufacturing.
Patent CN102952028A details a high-yield L-carnitine synthesis using Ru-catalysis. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel acrylonitrile-based route for Cefoselis sulfate side chains. Reduces costs and improves supply reliability for pharmaceutical intermediates manufacturing.
Patent CN106905350B reveals magnetic ionic liquid catalysis for thiazolo-pyridine derivatives, offering enhanced purity and scalable supply chain solutions.
Patent CN108285908B reveals a green enzymatic route for (S)-1-(2,6-dichloro-3-fluoro-phenyl) ethanol, offering superior purity and cost efficiency for API manufacturing.
Patent CN116143725A reveals a safe, low-cost route for homopiperazine. Eliminate high-pressure hydrogenation risks with our scalable pharmaceutical intermediate solutions.
Novel catalyst-free transesterification method for amisulpride ensures high purity and reduced environmental impact for global supply chains.
Patent CN104031069A reveals high-purity cefquinome sulfate synthesis. Optimized silylation and crystallization ensure supply chain stability and cost efficiency.
Patent CN113993851A details a novel Valsartan refining method reducing NDMA to ≤0.03ppm. Discover the cost-effective, scalable acid-base purification technology for high-purity API manufacturing.
Patent CN111170992B reveals a novel route for 5,6-dihydropyridin-2-one derivatives, offering high purity and reduced costs for Apixaban manufacturing supply chains.
Patent CN104262290B reveals high-yield pridinol mesylate synthesis. Optimized Grignard route ensures cost reduction and supply chain reliability for global buyers.